Early Failure of Frontline Rituximab-containing Chemoimmunotherapy in Diffuse Large B-Cell Lymphoma does not Predict Futility of Autologous Hematopoietic Cell Transplantation

The poor prognosis of diffuse large B-cell lymphoma (DLBCL) patients relapsing within 1-year of initial diagnosis after first-line rituximab-based chemoimmunotherapy has created controversy about the role of autologous transplantation (auto-HCT) in this setting. We compared auto-HCT outcomes of chem...

詳細記述

保存先:
書誌詳細
主要な著者: Hamadani, Mehdi, Hari, Parameswaran N., Zhang, Ying, Carreras, Jeanette, Akpek, Görgün, Aljurf, Mahmoud D., Ayala, Ernesto, Bachanova, Veronika, Chen, Andy I., Chen, Yi-Bin, Costa, Luciano J., Fenske, Timothy S., Freytes, César O., Ganguly, Siddhartha, Hertzberg, Mark S., Holmberg, Leona A., Inwards, David J., Kamble, Rammurti T., Kanfer, Edward J., Lazarus, Hillard M., Marks, David I., Nishihori, Taiga, Olsson, Richard, Reddy, Nishitha M., Rizzieri, David A., Savani, Bipin N., Solh, Melhem, Vose, Julie M., Wirk, Baldeep, Maloney, David G., Smith, Sonali M., Montoto, Silvia, Saber, Wael
フォーマット: Artigo
言語:Inglês
出版事項: 2014
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4194275/
https://ncbi.nlm.nih.gov/pubmed/25008330
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.06.036
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料